Shopping Cart
- Remove All
- Your shopping cart is currently empty
Triclabendazole (CGA89317) has been used in trials studying Parasitic Disease.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | 41 € | In Stock | |
50 mg | 59 € | In Stock | |
100 mg | 75 € | In Stock | |
200 mg | 96 € | In Stock | |
500 mg | 158 € | In Stock | |
1 mL x 10 mM (in DMSO) | 47 € | In Stock |
Description | Triclabendazole (CGA89317) has been used in trials studying Parasitic Disease. |
In vitro | Triclabendazole treatment produces percentage decreases of the fluke egg output by 15.3%, 4.3% and 36.6%, respectively, in sheep, dairy cows and heifers, these results indicate the presence of TCBZ-resistant Fasciola hepatica in sheep and cattle on this farm. [1] Triclabendazole sulphoxide (50 mg/mL) results in extensive damage to the tegument of triclabendazole-susceptible F. hepatica, whereas triclabendazole-resistant flukes shows only localized and relatively minor disruption of the tegument covering the spines. [2] |
Alias | CGA89317 |
Molecular Weight | 359.66 |
Formula | C14H9Cl3N2OS |
Cas No. | 68786-66-3 |
Smiles | CSC1=NC2=C(N1)C=C(Cl)C(OC1=C(Cl)C(Cl)=CC=C1)=C2 |
Relative Density. | 1.59 g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 60 mg/mL (166.82 mM), Sonication is recommended. H2O: < 1 mg/mL (insoluble or slightly soluble) Ethanol: < 1 mg/mL (insoluble or slightly soluble) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.